Once again there were no double-digit risers or fallers. Worst performer was AMYT:Amryt Pharma which dropped 9%. That alone accounted for the whole of this week's loss, plus some.
Share of the Week goes to OPTI:Optibiotix which only climbed 4%, but that was enough to counter all the other losses across the portfolio.
The gap gets worryingly narrow
The combined share and ISA accounts look like this
| Weekly Change | |||
| Portfolio cost | £43,339.81 | +£0 | |
| Portfolio sell value (bid price - commission) | £43,217.87 | (-0.3%) | -£722.81 |
| Potential profits | £5,193.28 | -£538.00 | |
| Yr 2 Dividends | £486.29 | +£0 | |
| Yr 2 Profit from sales | £2,401.06 | +£0 | |
| Yr 2 Average monthly cash profit | £280.67 | (7.8%) | -£6.90 |
| Total Dividends | £1,154.22 | +£0 | |
| Total Profit from sales | £6.241.32 | +£0 | |
| Average monthly cash profit | £329.41 | (9.1%) | -£3.64 |
| (Sold stocks profit + Dividends - Fees / Months) |
I've squeezed the table up a bit as the % figure for the performance could easily fit on the same line. Not sure why it took this long to work that out! The portfolios went back into the red, with most of the drop being due to decreasing AMYT:Amryt Pharma profits, but there were lots of other little losses contributing too. No contribution from IQE:IQE this week as the price stayed the same. Sales and dividend performance down to 9.1% so well below my 10% target. I just don't have anything to sell that I don't want to keep longer term.
Every time the green line gets above the red, down it goes again
The SIPP looks like this after week 80
| Weekly Change | |||
| Portfolio cost | £17,853.50 | +£384.79 | |
| Portfolio sell value (bid price - commission) | £19,880.17 | (11.4%%) | +£217.56 |
| Potential profits | £2,959.62 | +£140.95 | |
| Yr 2 Dividends | £294.95 | +£294.95 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £284.96 | (19.2%) | +£35.57 |
| Total Dividends | £708.15 | +£294.95 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £246.65 | (16.6%) | +£12.64 |
| (Sold stocks profit + Dividends - Fees / Months) |
Lots of action to report this week thanks to some generous dividends. CAML:Central Asia Metals, which is the best run company I invest in, paid out a socking £213.40, taking the total dividends for this share to £473.73. Without the dividends this share is returning 36% on my original investment. With the dividends it's up by 50%. I really should get more in my SIPP while the price is depressed slightly, as it was 250p back in February and is now only 220p with a P/E ratio of only 11.9, a recent expansion which will increase production, a huge pile of cash and no debt.
The other dividend was £81.56 from LGEN:Legal & General. A proper safe pension share!
There was some cash lying around in the account too so I took the opportunity to top up my OPTI:Optibiotix holding while they're subject to another dip. I was able to get another 520 shares at 71.7p costing £374.79. The timing was good, as the purchase price has now gone to 74p and I'm hoping time is running out to be able to get these at below 100p.
The sell value increased slightly over and above the extra money put in. That was all down to 4% rises in both OPTI:Optibiotix and LGEN:Legal & General, with a 3% dip in ARL:Atlantis Resources and 5% dip in TRX:Tissue Regenix reducing the gains.
The dividends lift average monthly performance by £12.64 a month and help keep this a spectacularly healthy figure.
Not as big a gap as a few months ago, but enough to offset the performance of the other accounts and keep the combined portfolios in the black.
The dreaded trading account looks looks this after week 46
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £335.55 | (-28.99%) | -£28.99 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.15 | (-5.3%) | +£0.05 |
| (Sold stocks profit + Dividends - Fees / Months) |
The only remaining share in this account is REDS:RedstoneConnect, which did a 1 for 100 consolidation this week. Rather than encouraging more investors, it contributed to a 6% decline resulting in my brave attempt at short term trading now being down by nearly 30% and basically an unmitigated disaster. Glad I'm just playing with £500!
I took out the KIBO:Kibo Mining shares too early else I could have aimed at creating a symmetrical graph, which would have been more fun than trying to make any money has been.
So the election is over and the Tory loony wing have power over the fragile majority which will crumble if the DUP aren't kept happy. Great - nice one Teresa, that's really going to improve our chances of reducing the impact of Brexit. Part of me is tickled that such an arrogant, opportunist attempt at grabbing a big majority has failed so badly. The optimist in me hopes that there will be a need for consensus and we can approach Brexit negotiations with a unified UK team, but that would be too much of a culture shock for our petty name-calling politics.
No news expected next week, so it's going to be a case of continued hope that OPTI:Optibiotix might announce what's happening with SBTX:Skinbiotherapeutics share distribution, or some signed contracts following the launch of LPLDL®at Vitafoods in May.
There's also an announcement due from JLP:Jubilee Platinum in June to confirm production at Hernic is fully ramped up, and anything that mentions earnings may reverse the current share price slide. Any news on what the hell is going on a Tjate would also help, as the value of that asset is completely ignored by the current share price, despite the obtaining of a mining licence. Let's see what the week has in store...
No comments:
Post a Comment